{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:07:48Z","timestamp":1790460468003,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["C-PJ-57-Exper-2019"],"award-info":[{"award-number":["C-PJ-57-Exper-2019"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","award":["MYIP 13188"],"award-info":[{"award-number":["MYIP 13188"]}],"id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofdiabetes.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Diabetes"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jcjd.2022.12.003","type":"journal-article","created":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T02:18:11Z","timestamp":1671848291000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence"],"prefix":"10.1016","volume":"47","author":[{"given":"Venkatesan","family":"Thiruvenkatarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0486-9013","authenticated-orcid":false,"given":"Joshua M.","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7450-5808","authenticated-orcid":false,"given":"Emily","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8959-5239","authenticated-orcid":false,"given":"Mahesh M.","family":"Umapathysivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagesh","family":"Nanjappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8498-9861","authenticated-orcid":false,"given":"Roelof","family":"Van Wijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-3671","authenticated-orcid":false,"given":"David","family":"Jesudason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjd.2022.12.003_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12875-022-01731-w","article-title":"Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: A cross-sectional study","volume":"23","author":"Hao","year":"2022","journal-title":"BMC Primary Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: A systematic review","volume":"123","author":"Thiruvenkatarajan","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jcjd.2022.12.003_bib3","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.9778\/cmajo.20170131","article-title":"Geographic variation in the provider of screening colonoscopy in Canada: A population-based cohort study","volume":"6","author":"Doumouras","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jcjd.2022.12.003_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.5946\/ce.2020.021","article-title":"A\u00a0survey of peri-colonoscopy management of anti-diabetic medications","volume":"53","author":"Lee","year":"2020","journal-title":"Clin Endosc"},{"key":"10.1016\/j.jcjd.2022.12.003_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/2050640619846365","article-title":"Antihyperglycemic therapy during colonoscopy preparation: A review and suggestions for practical recommendations","volume":"7","author":"Hochberg","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jcjd.2022.12.003_bib6","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.2337\/dc20-1244","article-title":"Periprocedural euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 inhibitor therapy during colonoscopy","volume":"43","author":"Meyer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib7","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.2337\/diabetes.54.10.3056","article-title":"Apical GLUT2: A major pathway of intestinal sugar absorption","volume":"54","author":"Kellett","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jcjd.2022.12.003_bib8","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium\u2013glucose cotransporter inhibitors: Effects on renal and intestinal glucose transport: From bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2036.2007.03406.x","article-title":"Review article: Bowel preparation for colonoscopy---the importance of adequate hydration","volume":"26","author":"Lichtenstein","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcjd.2022.12.003_bib10","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s10350-004-0592-1","article-title":"Physiologic effects of bowel preparation","volume":"47","author":"Holte","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jcjd.2022.12.003_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2886","article-title":"Ketosis and diabetic ketoacidosis in response to SGLT2 inhibitors: Basic mechanisms and therapeutic perspectives","volume":"33","author":"Qiu","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcjd.2022.12.003_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MED.0000000000000311","article-title":"An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Hsia","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.jcjd.2022.12.003_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20524\/aog.2016.0005","article-title":"Optimizing bowel preparation for colonoscopy: A guide to enhance quality of visualization","volume":"29","author":"Bechtold","year":"2016","journal-title":"Ann Gastroenterol"},{"issue":"Suppl. 2","key":"10.1016\/j.jcjd.2022.12.003_bib14","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1038\/sj.ejcn.1601904","article-title":"Effects of changes in hydration on protein, glucose and lipid metabolism in man: Impact on health","volume":"57","author":"Keller","year":"2003","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jcjd.2022.12.003_bib15","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/0140-6736(93)90828-5","article-title":"Cellular hydration state: An important determinant of protein catabolism in health and disease","volume":"341","author":"Haussinger","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jcjd.2022.12.003_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/meta.2001.20194","article-title":"Differential effects of fasting and dehydration in the pathogenesis of diabetic ketoacidosis","volume":"50","author":"Burge","year":"2001","journal-title":"Metabolism"},{"key":"10.1016\/j.jcjd.2022.12.003_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0310057X1804600212","article-title":"Postoperative euglycaemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitors (gliflozins): A report of two cases and review of the literature","volume":"46","author":"Chacko","year":"2018","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib19","unstructured":"Australian Diabetes Society. Periprocedural Diabetic Ketoacidosis With SGLT2 Inhibitor Use. Melbourne: ADS, January 2020."},{"key":"10.1016\/j.jcjd.2022.12.003_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: A review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jcjd.2022.12.003_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/cen.14621","article-title":"Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use","volume":"96","author":"Hamblin","year":"2022","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.jcjd.2022.12.003_bib22","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.2337\/dc21-0256","article-title":"Comment on Hamblin et\u00a0al. Capillary ketone concentrations at the time of colonoscopy: A cross-sectional study with implications for SGLT2 inhibitor-treated type 2 diabetes","volume":"44","author":"Thiruvenkatarajan","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib23","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/anae.14251","article-title":"Sodium-glucose co-transporter type-2 inhibitors: Pharmacology and peri-operative considerations","volume":"73","author":"Milder","year":"2018","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jcjd.2022.12.003_bib24","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.2337\/dc21-1870","article-title":"Sodium\u2013glucose cotransporter 2 inhibitor\u2013linked pericolonoscopy hyperketonemia: A retrospective study","volume":"45","author":"Thiruvenkatarajan","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib25","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.2337\/dc21-0256","article-title":"Capillary ketone concentrations at the time of colonoscopy: A cross-sectional study with implications for SGLT2 inhibitor-treated type 2 diabetes","volume":"44","author":"Hamblin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcjd.2022.12.003_bib26","article-title":"Letter to the Editor: Response to Hamblin et al body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use","author":"Umapathysivam","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcjd.2022.12.003_bib27","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: A South Australian clinical case series and Australian spontaneous adverse event notifications","volume":"41","author":"Meyer","year":"2018","journal-title":"Diabetes Care"}],"container-title":["Canadian Journal of Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267122004440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499267122004440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:39:14Z","timestamp":1761493154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499267122004440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1499267122004440"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjd.2022.12.003","relation":{},"ISSN":["1499-2671"],"issn-type":[{"value":"1499-2671","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjd.2022.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Canadian Diabetes Association.","name":"copyright","label":"Copyright"}]}}